Cargando…

The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article)

OBJECTIVES: This meta-analysis aimed to identify the therapeutic effect of 0.01% atropine with orthokeratology on ocular axial elongation for myopia children. METHODS: We searched PubMed, Cochrane Library, and CBM databases from inception to July 1st, 2021. Meta-analysis was conducted using STATA ve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yan, Liu, Jiasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276445/ https://www.ncbi.nlm.nih.gov/pubmed/35550467 http://dx.doi.org/10.1097/MD.0000000000029191

Ejemplares similares

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial
por: Kinoshita, Nozomi, et al.
Publicado: (2020)

Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial
por: Yu, Shiao, et al.
Publicado: (2022)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

A STROBE-compliant case–control study: Effects of cumulative doses of topical atropine on intraocular pressure and myopia progression
por: Yu, Teng-Chieh, et al.
Publicado: (2020)

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
por: Yan, Chunxiao, et al.
Publicado: (2023)

Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial
por: Yuan, Ying, et al.
Publicado: (2021)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Overnight orthokeratology is comparable with atropine in controlling myopia
por: Lin, Hui-Ju, et al.
Publicado: (2014)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis
por: Chen, Jun, et al.
Publicado: (2019)

The control effect of orthokeratology on axial length elongation in Chinese children with myopia
por: Zhu, Meng-Jun, et al.
Publicado: (2014)

Factors related to axial length elongation and myopia progression in orthokeratology practice
por: Wang, Bingjie, et al.
Publicado: (2017)

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia
por: Wan, Lei, et al.
Publicado: (2018)

Effectiveness of multiple therapeutic strategies in neovascular glaucoma patients: A PRISMA-compliant network meta-analysis
por: Dong, Zixian, et al.
Publicado: (2018)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Efficacy of cataract surgery in patients with uveitis: A STROBE-compliant article
por: Zhang, Yinglei, et al.
Publicado: (2017)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Long-Term Comparison of Posterior Chamber Phakic Intraocular Lens With and Without a Central Hole (Hole ICL and Conventional ICL) Implantation for Moderate to High Myopia and Myopic Astigmatism: Consort-Compliant Article
por: Shimizu, Kimiya, et al.
Publicado: (2016)

Corneal perforation in ocular cicatricial pemphigoid: A CARE-compliant case report
por: Hwang, Suan, et al.
Publicado: (2021)

A CARE-compliant article: ipsilateral progressive idiopathic lipid keratopathy: A case report
por: Pang, Yilin, et al.
Publicado: (2019)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

Categorisation of myopia progression by change in refractive error and axial elongation and their impact on benefit of myopia control using orthokeratology
por: Cho, Pauline, et al.
Publicado: (2020)

A case report of phacolytic glaucoma in lens cortex behind posterior capsule: A CARE-compliant article
por: Han, Rui-Juan, et al.
Publicado: (2023)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Risk factors for rapid axial length elongation with low concentration atropine for myopia control
por: Fu, Aicun, et al.
Publicado: (2021)

Clinical efficacy analysis of Ahmed glaucoma valve implantation in neovascular glaucoma and influencing factors: A STROBE-compliant article
por: He, Ye, et al.
Publicado: (2017)

Clinical application of TICL implantation for ametropia following deep anterior lamellar keratoplasty for keratoconus: A CONSORT-compliant article
por: Qin, Qin, et al.
Publicado: (2017)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fumsat42qoebrtf3encmddake8